The idea that he is promoting the drug to boost the price of a mutual fund in which he owns shares is perhaps the most ludicrous conspiracy theory yet.
Though it’s unlikely. Sanofi is a French drugmaker that produces the hydroxychloroquine-label Plaquenil. The drug, however, isn’t patented, it isn’t particularly difficult to manufacture, and there are a bunch of giant pharma companies around the world already ramping up production of generic versions. Sanofi is less likely to benefit than Novartis or Bayer (check everyone’s mutual funds, pronto!).
No comments:
Post a Comment